Rakuten Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$773 Buy
2
+1
+100% +$371 ﹤0.01% 748
2026
Q1
$293 Hold
1
﹤0.01% 778
2025
Q4
$351 Sell
1
-12
-92% -$4.05K ﹤0.01% 785
2025
Q3
$4.2K Buy
13
+12
+1,200% +$3.73K ﹤0.01% 540
2025
Q2
$389 Sell
1
-25
-96% -$10.1K ﹤0.01% 732
2025
Q1
$11.3K Buy
26
+14
+117% +$5.62K 0.01% 384
2024
Q4
$4.43K Buy
12
+10
+500% +$4.18K ﹤0.01% 492
2024
Q3
$1.04K Hold
2
﹤0.01% 569
2024
Q2
$1.08K Hold
2
﹤0.01% 546
2024
Q1
$1.04K Buy
2
+1
+100% +$497 ﹤0.01% 564
2023
Q4
$472 Buy
+1
New +$462 ﹤0.01% 524

Other funds holding ELV

Rakuten Securities's ELV Position: Q2 2026 in Review

Rakuten Securities increased its Elevance Health (ELV) stake by 100% in Q2 2026, buying an estimated $371 and bringing the position to 2 shares worth $773. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Rakuten Securities first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.3K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Rakuten Securities held 2 shares of Elevance Health worth $773 as of Q2 2026.
  • Rakuten Securities bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #748 holding.
  • Rakuten Securities first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Elevance Health position peaked at $11.3K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.